Pricing updated 2016-05-24. Prices are subject to change without notice.
|Formulation||A crystalline solid|
WARNING - This product is not for human or veterinary use.
|Shipping||Room temperature in continental US; may vary elsewhere|
|Stability||As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly|
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, and GC-MS data.
Liston, T.E., and Roberts, L.J. Transformation of prostaglandin D2 to 9.alpha.,11.beta.-
O'Sullivan, S., Dahlén, B., Dahlén, S., et al. Increased urinary excretion of the prostaglandin D2 metabolite 9.alpha.,11.beta.-
Coleman, R.A., and Sheldrick, R.L.G. Prostanoid-
Lepak, N.M., and Serrero, G. Inhibition of adipose differentiation by 9.alpha., 11.beta.-
Pugliese, G., Spokas, E.G., Marcinkiewicz, E., et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9.alpha.,11.beta.-
We offer you the deep and diverse knowledge of more than 100 in-house scientists and the expertise that comes from more than three decades of designing and developing the tools to advance biomedical research.
Cayman is know as a partner to scientists worldwide, responding to your needs with services in: